NCATS Funding Opportunity: Pfizer’s Centers for Therapeutic Innovation (CTI) Program

On September 6, 2016, NCATS announced an opportunity for NIH intramural researchers to submit proposals to collaborate with Pfizer’s Centers for Therapeutic Innovation (CTI).  Pfizer’s CTI program pairs leading researchers with Pfizer resources to help the scientists pursue scientific and medical advances through joint therapeutic development. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. Goals include identifying biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer and moving the compounds into the clinic to test them.

The first call for proposals is due to the investigator’s NIH Institute or Center’s technology transfer office by Oct. 7, 2016. Technology transfer staff must submit the pre-proposals by Oct. 14, 2016, via the Pfizer CTI submission portal at

How to Apply
Frequently Asked Questions
Learn More about Pfizer’s CTI for NIH Researchers